CN114948786A - 一款含有芋螺肽和ⅰ型胶原的延缓衰老和紧致皮肤的组合物 - Google Patents
一款含有芋螺肽和ⅰ型胶原的延缓衰老和紧致皮肤的组合物 Download PDFInfo
- Publication number
- CN114948786A CN114948786A CN202210527989.6A CN202210527989A CN114948786A CN 114948786 A CN114948786 A CN 114948786A CN 202210527989 A CN202210527989 A CN 202210527989A CN 114948786 A CN114948786 A CN 114948786A
- Authority
- CN
- China
- Prior art keywords
- phase
- skin
- parts
- water
- conditioning agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000032683 aging Effects 0.000 title claims abstract description 20
- 102000012422 Collagen Type I Human genes 0.000 title claims abstract description 19
- 108010022452 Collagen Type I Proteins 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 31
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 16
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 12
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 12
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004475 Arginine Substances 0.000 claims abstract description 11
- 240000001548 Camellia japonica Species 0.000 claims abstract description 11
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 11
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 10
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 10
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 10
- 229930003799 tocopherol Natural products 0.000 claims abstract description 10
- 229960001295 tocopherol Drugs 0.000 claims abstract description 10
- 239000011732 tocopherol Substances 0.000 claims abstract description 10
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 10
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 10
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 9
- 241000221095 Simmondsia Species 0.000 claims abstract description 8
- 235000018597 common camellia Nutrition 0.000 claims abstract description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 8
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims abstract description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 8
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940087291 tridecyl alcohol Drugs 0.000 claims abstract description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 6
- 229960001631 carbomer Drugs 0.000 claims abstract description 6
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims abstract description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920002401 polyacrylamide Polymers 0.000 claims abstract description 6
- 229940075582 sorbic acid Drugs 0.000 claims abstract description 6
- 235000010199 sorbic acid Nutrition 0.000 claims abstract description 6
- 239000004334 sorbic acid Substances 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 230000003750 conditioning effect Effects 0.000 claims description 34
- 238000001816 cooling Methods 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 229920001184 polypeptide Polymers 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 102000001187 Collagen Type III Human genes 0.000 claims description 8
- 108010069502 Collagen Type III Proteins 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 7
- 229920001436 collagen Polymers 0.000 claims description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 5
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 5
- 229930182478 glucoside Natural products 0.000 claims description 5
- 150000008131 glucosides Chemical class 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000006071 cream Substances 0.000 abstract description 10
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- 230000009758 senescence Effects 0.000 abstract description 2
- 231100000245 skin permeability Toxicity 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 108050003126 conotoxin Proteins 0.000 abstract 2
- 229940083957 1,2-butanediol Drugs 0.000 abstract 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- 229960005150 glycerol Drugs 0.000 abstract 1
- 229940031674 laureth-7 Drugs 0.000 abstract 1
- 206010040954 Skin wrinkling Diseases 0.000 description 17
- 230000037303 wrinkles Effects 0.000 description 16
- 238000012360 testing method Methods 0.000 description 11
- 230000003712 anti-aging effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 4
- 108010038807 Oligopeptides Proteins 0.000 description 4
- 235000006467 Camellia japonica Nutrition 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 244000044822 Simmondsia californica Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 241000235342 Saccharomycetes Species 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,包括甘油、卡波姆、透明质酸钠、对羟基苯乙酮、乳化剂、辛酸/癸酸甘油三酯、十三烷醇偏苯三酸酯、棕榈酸异丙酯、聚二甲基硅氧烷、聚二甲基硅氧烷醇、山茶籽油、霍霍巴籽油1、生育酚、精氨酸、聚丙烯酰胺、C13‑14异链烷烃、月桂醇聚醚‑7、Ⅰ型胶原、1,2‑戊二醇、1,2‑己二醇、山梨酸、芋螺肽、1,2‑己二醇、丁二醇和水。本发明组分配方温和无刺激,具有协同增效,对皮肤的渗透性好,能够最快速地有效地滋润皮肤,紧致皮肤,深层保湿锁水且持续性久,具有延缓衰老作用。
Description
技术领域
本发明属于化妆品领域,具体地说,是一种抗衰老面霜。
背景技术
近年来,随着经济的发展和生活水平的提高,人们越来越重视皮肤的保养了,从而使得化妆品发展迅速。皮肤作为机体的一部分,缺少水分时会出现干燥、紧绷、粗糙皮肤暗沉;当皮肤水分含量极低时,皮肤屏障容易受损,紫外线、灰尘、微生物等外界因素更容易攻击皮肤进而出现老化、敏感等皮肤问题,因此充足的水分能够保证皮肤功能正常,促进活跃皮肤代谢,同时也是维持皮肤状态、延缓衰老的基本条件。现有的保湿类化妆品一般只注重临时保湿效果,忽略紧致皮肤对于皮肤的长期保湿功效,造成产品保湿效果差的问题。
发明内容
本发明针对现有技术的不足之处,提供一种含有芋螺肽和I型胶原的延缓衰老和紧致皮肤的抗衰霜。
为解决上述的技术问题,本发明采用如下技术方案:一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,由包括以下重量百分比的组分制成:
A相组分包括:甘油7~10、卡波姆0.1~0.3、透明质酸钠0.04~0.07、水0.002~0.005、对羟基苯乙酮0.3~0.6;
B相组分包括:乳化剂2.5~3.5、辛酸/癸酸甘油三酯2~4、十三烷醇偏苯三酸酯2~3、棕榈酸异丙酯2~3、聚二甲基硅氧烷0.6~1、聚二甲基硅氧烷醇0.1~0.3、山茶(CAMELLIA JAPONICA)籽油0.8~1.5、霍霍巴(SIMMONDSIA CHINENSIS)籽油0.8~1.5、生育酚(维生素E)0.07~0.12;
C相组分包括:精氨酸0.2~0.4、聚丙烯酰胺0.2~0.3、C13-14异链烷烃0.1~0.2、月桂醇聚醚-7 0.03~0.05、水0.15~0.23;
D相组分包括第一皮肤调理剂、第二皮肤调理剂和第三皮肤调理剂,其中,
所述第一皮肤调理剂由包括以下重量百分比的组分组成:Ⅰ型胶原0.02~ 0.04、水9~10、1,2-戊二醇0.35~0.5、1,2-己二醇0.03~0.06、山梨酸 0.001~0.002;
所述第二皮肤调理剂由包括以下重量百分比的组分组成:芋螺肽(精氨酸 /赖氨酸多肽)0.00004~0.00006、水1.5~2.3;
所述第三皮肤调理剂由包括以下重量百分比的组分组成:1,2-己二醇 0.4~0.8、丁二醇0.1~0.3;
E相组分包括:水余量。
其中,所述水均采用去离子水或蒸馏水。
优选的,所述乳化剂由包括以下重量百分比的组分组成:甲基葡糖倍半硬脂酸酯0.4~0.7、鲸蜡硬脂醇1.8~2.3、鲸蜡硬脂基葡糖苷0.3~0.5。
优选的,D相组分还包括有第四皮肤调理剂,所述第四皮肤调理剂由包括以下重量百分比的组分组成:水0.03~0.06、甘油0.04~0.07、丁二醇0.002~ 0.005、III型胶原0.001~0.002、透明质酸0.002~0.005、寡肽-1 0.000002~ 0.000003、酵母菌多肽类0.000001~0.000002、六肽-1 0.0001~0.00015。
本方案A相组分采用透明质酸钠和甘油作为保湿因子,对皮肤起润滑与滋养作用。B相组分中采用辛酸/癸酸甘油三酯、十三烷醇偏苯三酸酯、棕榈酸异丙酯、聚二甲基硅氧烷、聚二甲基硅氧烷醇等作为油相基底,具有很好的润肤作用并且价格便宜,山茶籽油能使人的皮肤光滑、润泽,霍霍巴籽油能够促进皮肤的深层锁水,生育酚在抗衰老、美白祛斑方面有卓著的功效。C相组分采用精氨酸作为PH中和剂,对人体的皮肤能够起到增强免疫功能,调节肌肤水分、酸碱、平衡油脂,可提高敏感性肌肤的抗敏性,并能预防皱纹的产生,另外其与 A相组分中的透明质酸钠、B相组分中的生育酚和D相组分中的Ⅰ型胶原和III 型胶原能够很好的配伍。D相组分采用了Ⅰ型胶原、芋螺肽、III型胶原、寡肽、多肽等多种皮肤调理剂,对于延缓衰老、淡纹、抚平皮肤皱纹、紧致肌肤具有巨大的作用。
优选的,本发明的最优组分为:
A相组分包括:甘油8、卡波姆0.2、透明质酸钠0.057、水0.003、对羟基苯乙酮0.5;
B相组分包括:乳化剂3.1、辛酸/癸酸甘油三酯3、十三烷醇偏苯三酸酯 2、棕榈酸异丙酯2、聚二甲基硅氧烷0.85、聚二甲基硅氧烷醇0.15、山茶 (CAMELLIA JAPONICA)籽油1、霍霍巴(SIMMONDSIA CHINENSIS)籽油1、生育酚(维生素E)0.1;其中,所述乳化剂包括:甲基葡糖倍半硬脂酸酯0.6、鲸蜡硬脂醇2.1、鲸蜡硬脂基葡糖苷0.4。
C相组分包括:精氨酸0.24、聚丙烯酰胺0.2、C13-14异链烷烃0.12、月桂醇聚醚-70.03、水0.15;
D相组分包括第一皮肤调理剂、第二皮肤调理剂、第三皮肤调理剂和所述第四皮肤调理剂,其中,
所述第一皮肤调理剂包括:Ⅰ型胶原0.02、水9.479、1,2-戊二醇0.45、 1,2-己二醇0.05、山梨酸0.001;
所述第二皮肤调理剂包括:芋螺肽(精氨酸/赖氨酸多肽)0.000048、水 1.999952;
所述第三皮肤调理剂包括:1,2-己二醇0.6、丁二醇0.2;
所述第四皮肤调理剂包括:水0.0428867、甘油0.05、丁二醇0.003、III 型胶原0.001、透明质酸0.003、寡肽-1 0.0000023、酵母菌多肽类0.000001、六肽-1 0.00011;
E相组分包括:水余量。
本发明还公开上述一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物的制备方法,包括的步骤如下:
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放;
S2.将A相组分和E相组分加入真空乳化锅加热90℃,将B相组分加入真空油相锅加热80℃,待溶解完全;
S3.将B相组分加入A相组分中,均质3-5min,保温搅拌15-20min;降温,降温至60-65℃加入C相,均质5分钟搅拌均匀;
S4.降温至40-45℃,加入D相,搅拌均匀;
S5.降温至常温,过100目滤布出料,静置。
与现有技术相比,本发明具有如下有益效果:本发明组分配方温和无刺激,具有协同增效,对皮肤的渗透性好,能够最快速地有效地滋润皮肤,紧致皮肤,深层保湿锁水且持续性久,具有延缓衰老作用。
具体实施例
为了更好地阐述本发明内容,下面用若干较佳的具体实施例进行说明。但这些具体实施例只是为了说明本发明的内容,而不是对本发明内容进行限制。
一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,由包括以下重量百分比的组分制成:
A相组分包括:甘油7~10、卡波姆0.1~0.3、透明质酸钠0.04~0.07、水0.002~0.005、对羟基苯乙酮0.3~0.6;
B相组分包括:乳化剂2.5~3.5、辛酸/癸酸甘油三酯2~4、十三烷醇偏苯三酸酯2~3、棕榈酸异丙酯2~3、聚二甲基硅氧烷0.6~1、聚二甲基硅氧烷醇0.1~0.3、山茶(CAMELLIA JAPONICA)籽油0.8~1.5、霍霍巴(SIMMONDSIA CHINENSIS)籽油0.8~1.5、生育酚(维生素E)0.07~0.12;
C相组分包括:精氨酸0.2~0.4、聚丙烯酰胺0.2~0.3、C13-14异链烷烃0.1~0.2、月桂醇聚醚-7 0.03~0.05、水0.15~0.23;
D相组分包括第一皮肤调理剂、第二皮肤调理剂和第三皮肤调理剂,其中,
所述第一皮肤调理剂由包括以下重量百分比的组分组成:Ⅰ型胶原0.02~ 0.04、水9~10、1,2-戊二醇0.35~0.5、1,2-己二醇0.03~0.06、山梨酸 0.001~0.002;
所述第二皮肤调理剂由包括以下重量百分比的组分组成:芋螺肽(精氨酸 /赖氨酸多肽)0.00004~0.00006、水1.5~2.3;
所述第三皮肤调理剂由包括以下重量百分比的组分组成:1,2-己二醇 0.4~0.8、丁二醇0.1~0.3;
E相组分包括:水余量。
其中,所述水均采用去离子水或蒸馏水。
优选的,所述乳化剂由包括以下重量百分比的组分组成:甲基葡糖倍半硬脂酸酯0.4~0.7、鲸蜡硬脂醇1.8~2.3、鲸蜡硬脂基葡糖苷0.3~0.5。
优选的,D相组分还包括有第四皮肤调理剂,所述第四皮肤调理剂由包括以下重量百分比的组分组成:水0.03~0.06、甘油0.04~0.07、丁二醇0.002~ 0.005、III型胶原0.001~0.002、透明质酸0.002~0.005、寡肽-1 0.000002~ 0.000003、酵母菌多肽类0.000001~0.000002、六肽-1 0.0001~0.00015。
本方案A相组分采用透明质酸钠和甘油作为保湿因子,对皮肤起润滑与滋养作用。B相组分中采用辛酸/癸酸甘油三酯、十三烷醇偏苯三酸酯、棕榈酸异丙酯、聚二甲基硅氧烷、聚二甲基硅氧烷醇等作为油相基底,具有很好的润肤作用并且价格便宜,山茶籽油能使人的皮肤光滑、润泽,霍霍巴籽油能够促进皮肤的深层锁水,生育酚在抗衰老、美白祛斑方面有卓著的功效。C相组分采用精氨酸作为PH中和剂,对人体的皮肤能够起到增强免疫功能,调节肌肤水分、酸碱、平衡油脂,可提高敏感性肌肤的抗敏性,并能预防皱纹的产生,另外其与 A相组分中的透明质酸钠、B相组分中的生育酚和D相组分中的Ⅰ型胶原和III 型胶原能够很好的配伍。D相组分采用了Ⅰ型胶原、芋螺肽、III型胶原、寡肽、多肽等多种皮肤调理剂,对于延缓衰老、淡纹、抚平皮肤皱纹、紧致肌肤具有巨大的作用。
本发明还公开上述一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物的制备方法,包括的步骤如下:
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放;
S2.将A相组分和E相组分加入真空乳化锅加热90℃,将B相组分加入真空油相锅加热80℃,待溶解完全;
S3.将B相组分加入A相组分中,均质3-5min,保温搅拌15-20min;降温,降温至60-65℃加入C相,均质5分钟搅拌均匀;
S4.降温至40-45℃,加入D相,搅拌均匀;
S5.降温至常温,过100目滤布出料,静置。
实施例1
其制备方法如下:
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放;
S2.将A相组分和E相组分加入真空乳化锅加热90℃,将B相组分加入真空油相锅加热80℃,待溶解完全;
S3.将B相组分加入A相组分中,均质5min,保温搅拌16min;降温,降温至62℃加入C相,均质5分钟搅拌均匀;
S4.降温至42℃,加入D相,搅拌均匀;
S5.降温至常温,过100目滤布出料,静置。
安全性、功效性评价试验
本发明抗衰霜的安全性和功效性评估如下:
抗衰霜的安全性测试方法:分别选30名试用者进行实施例1的抗衰霜产品进行斑贴试验,通过肉眼观察,24小时后观察皮肤反应:
反应程度 | 皮肤反应 |
0 | 无不良反应 |
1 | 仅有微弱红斑 |
2 | 发生红斑反应 |
3 | 发生疱疹反应 |
4 | 发生融合性疱疹反应 |
经过斑贴实验,上述实施例1的试用者均无不良反应。
抗衰霜的功效性测试为在同一地区,同一时间筛选60例皮肤出现老化的女性志愿者,年龄38-55岁,平均年龄45岁。志愿者入选标准:眼部周围都有轻度或中度的皱纹、皮肤干燥,弹性降低,出现皱纹,色素沉着、肤色灰暗等皮肤老化现象;志愿者使用实施例1中的抗衰霜,在早、晚进行脸部清洁后,涂抹于眼部周围并进行轻轻按压至吸收,测试时间为90天,参加试验的志愿者每天反馈眼部皮肤变化情况和使用感受,进行记录情况、汇总数据,并对受试者进行效果评价。
皮肤老化评估:通过观察受试者的受试区来评价(鱼尾纹、眉间纹、前额皱纹)。
评判标准:没有皱纹;轻度:2-3条皱纹,长度<1cm;中度:3-6条皱纹,长度<2cm;重度:有数条皱纹长度3cm以上,同时伴有浅皱纹。
表8:试验结束后各组受试者的皮肤老化情况统计
没有皱纹(例) | 轻度(例) | 中度(例) | 重度(例) |
52 | 7 | 1 | 0 |
经过上述试验可知,本发明实施例1所制备的抗衰霜能够缓解和预防皱纹的产生,从而达到抗衰老的目的。
值得注意的是,本发明使用的原料和试剂的来源均为市售,本发明未注明具体条件的实验方法,通常按照常规条件进行,或厂商建议的条件进行。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效置换方式,都包含在本发明的保护范围之内。
Claims (7)
1.一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,其特征在于,由包括以下重量百分比的组分制成:
A相组分包括:甘油7~10、卡波姆0.1~0.3、透明质酸钠0.04~0.07、水0.002~0.005、对羟基苯乙酮0.3~0.6;
B相组分包括:乳化剂2.5~3.5、辛酸/癸酸甘油三酯2~4、十三烷醇偏苯三酸酯2~3、棕榈酸异丙酯2~3、聚二甲基硅氧烷0.6~1、聚二甲基硅氧烷醇0.1~0.3、山茶籽油0.8~1.5、霍霍巴籽油0.8~1.5、生育酚0.07~0.12;
C相组分包括:精氨酸0.2~0.4、聚丙烯酰胺0.2~0.3、C13-14异链烷烃0.1~0.2、月桂醇聚醚-7 0.03~0.05、水0.15~0.23;
D相组分包括第一皮肤调理剂、第二皮肤调理剂和第三皮肤调理剂,其中,所述第一皮肤调理剂由包括以下重量百分比的组分组成:Ⅰ型胶原0.02~0.04、水9~10、1,2-戊二醇0.35~0.5、1,2-己二醇0.03~0.06、山梨酸0.001~0.002;所述第二皮肤调理剂由包括以下重量百分比的组分组成:芋螺肽0.00004~0.00006、水1.5~2.3;所述第三皮肤调理剂由包括以下重量百分比的组分组成:1,2-己二醇0.4~0.8、丁二醇0.1~0.3;
E相组分包括:水 余量。
2.根据权利要求1所述的一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,其特征在于:所述乳化剂由包括以下重量百分比的组分组成:甲基葡糖倍半硬脂酸酯0.4~0.7、鲸蜡硬脂醇1.8~2.3、鲸蜡硬脂基葡糖苷0.3~0.5。
3.根据权利要求1所述的一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,其特征在于:D相组分还包括有第四皮肤调理剂,所述第四皮肤调理剂由包括以下重量百分比的组分组成:水0.03~0.06、甘油0.04~0.07、丁二醇0.002~0.005、III型胶原0.001~0.002、透明质酸0.002~0.005、寡肽-1 0.000002~0.000003、酵母菌多肽类0.000001~0.000002、六肽-1 0.0001~0.00015。
4.根据权利要求1所述的一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,其特征在于,由包括以下重量百分比的组分制成:
A相组分包括:甘油8、卡波姆0.2、透明质酸钠0.057、水0.003、对羟基苯乙酮0.5;
B相组分包括:乳化剂3.1、辛酸/癸酸甘油三酯3、十三烷醇偏苯三酸酯2、棕榈酸异丙酯2、聚二甲基硅氧烷0.85、聚二甲基硅氧烷醇0.15、山茶籽油1、霍霍巴籽油1、生育酚0.1;
C相组分包括:精氨酸0.24、聚丙烯酰胺0.2、C13-14异链烷烃0.12、月桂醇聚醚-70.03、水0.15;
D相组分包括第一皮肤调理剂、第二皮肤调理剂和第三皮肤调理剂,其中,
所述第一皮肤调理剂包括:Ⅰ型胶原0.02、水9.479、1,2-戊二醇0.45、1,2-己二醇0.05、山梨酸0.001;
所述第二皮肤调理剂包括:芋螺肽0.000048、水1.999952;
所述第三皮肤调理剂包括:1,2-己二醇0.6、丁二醇0.2;
E相组分包括:水 余量。
5.根据权利要求4所述的一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,其特征在于:其中,所述乳化剂包括:甲基葡糖倍半硬脂酸酯0.6、鲸蜡硬脂醇2.1、鲸蜡硬脂基葡糖苷0.4。
6.根据权利要求4所述的一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物,其特征在于:D相组分还包括有第四皮肤调理剂,所述第四皮肤调理剂包括:水0.0428867、甘油0.05、丁二醇0.003、III型胶原0.001、透明质酸0.003、寡肽-1 0.0000023、酵母菌多肽类0.000001、六肽-1 0.00011。
7.根据权利要求1-6任一所述的一款含有芋螺肽和Ⅰ型胶原的延缓衰老和紧致皮肤的组合物的制备方法,其特征在于,其步骤如下:
S1.准确称量配方中各种原料,用干净并消毒好的器皿盛放;
S2.将A相组分和E相组分加入真空乳化锅加热90℃,将B相组分加入真空油相锅加热80℃,待溶解完全;
S3.将B相组分加入A相组分中,均质3-5min,保温搅拌15-20min;降温,降温至60-65℃加入C相,均质5分钟搅拌均匀;
S4.降温至40-45℃,加入D相,搅拌均匀;
S5.降温至常温,过100目滤布出料,静置。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210527989.6A CN114948786A (zh) | 2022-05-16 | 2022-05-16 | 一款含有芋螺肽和ⅰ型胶原的延缓衰老和紧致皮肤的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210527989.6A CN114948786A (zh) | 2022-05-16 | 2022-05-16 | 一款含有芋螺肽和ⅰ型胶原的延缓衰老和紧致皮肤的组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114948786A true CN114948786A (zh) | 2022-08-30 |
Family
ID=82984276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210527989.6A Pending CN114948786A (zh) | 2022-05-16 | 2022-05-16 | 一款含有芋螺肽和ⅰ型胶原的延缓衰老和紧致皮肤的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114948786A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107875067A (zh) * | 2017-12-19 | 2018-04-06 | 湖南御家化妆品制造有限公司 | 皮肤细致组合物及其应用 |
CN113648235A (zh) * | 2021-08-24 | 2021-11-16 | 广州优然生物科技有限公司 | 一种即时祛皱的组合物、眼膜精华液、祛皱化妆品及应用 |
-
2022
- 2022-05-16 CN CN202210527989.6A patent/CN114948786A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107875067A (zh) * | 2017-12-19 | 2018-04-06 | 湖南御家化妆品制造有限公司 | 皮肤细致组合物及其应用 |
CN113648235A (zh) * | 2021-08-24 | 2021-11-16 | 广州优然生物科技有限公司 | 一种即时祛皱的组合物、眼膜精华液、祛皱化妆品及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112472631B (zh) | 一种多效眼部精华及其制备方法 | |
CN112641694B (zh) | 一种美白精华乳及其制备方法 | |
CN112494399A (zh) | 一种含酵母菌大米发酵产物滤液的保湿亮肤修复精华及其制备方法 | |
CN112569133A (zh) | 紧致抗皱精华霜及其制备方法 | |
CN114288216A (zh) | 一种抗氧化抗糖化组合物及其制备方法 | |
CN113876681A (zh) | 一种具有提高皮肤光泽度功效的面霜组合物及其制备方法和应用 | |
CN115300447A (zh) | 一种晚用面部皮肤护肤组合物及其制备方法 | |
CN117243844A (zh) | 一种含有胶原的护肤品精华液及其制备方法和用途 | |
CN112773761B (zh) | 一种化妆品组合物、精华液及其制备方法 | |
CN110787074A (zh) | 一种淡化细纹的组合物 | |
CN114099393A (zh) | 一种具有紧致与抗衰功效的组合物及其制备方法和应用 | |
CN111434332A (zh) | 滋养修护乳液及其制备方法 | |
CN111700849A (zh) | 一种美白组合物、化妆品和应用 | |
CN111920701A (zh) | 一种含鱼鳞胶原蛋白的抗氧化精华液的制备方法及精华液和应用 | |
CN112190507A (zh) | 一种含有茯苓提取物的祛黑眼圈抗皱组合物及其制备方法、应用 | |
CN116637042A (zh) | 一种祛皱抗衰护肤品及其制备方法和应用 | |
CN114948786A (zh) | 一款含有芋螺肽和ⅰ型胶原的延缓衰老和紧致皮肤的组合物 | |
CN116327674A (zh) | 一种抗皱紧致微纳米精华乳及制备方法 | |
CN110812262A (zh) | 一种抗皱紧肤组合物 | |
CN113712894B (zh) | 一种具有保湿舒缓功效的精华乳组合物及其制备方法和应用 | |
CN113749972B (zh) | 一种具有抗皱效果的组合物及其在化妆品中的应用 | |
CN114306194B (zh) | 一种含脐带血提取物的祛斑化妆品组合物、祛斑霜及其制备方法 | |
CN113633599B (zh) | 一种含铁皮石斛提取物的肌底精华液及其制备方法 | |
CN114569508A (zh) | 一种含胶原成分的保湿润肤面霜及其制备方法 | |
CN112220706B (zh) | 一种抗衰老组合物、面霜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |